Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.069 | 0.7 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |